ILM-03

N/A

Report date: 2024/09/04 10:05:58

Base Information

Drug NameILM-03
Drug Alias NameILM-03ILM03
ClassificationBiologics
Mechanisms of ActionSynuclein alpha modulators
TargetsSynuclein alpha
Therapy Area/IndicationsSynucleinopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIllimis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIllimis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSynucleinopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A